Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kristina Dunder"'
Publikováno v:
Diabetes, Obesity & Metabolism
Since 2005, more than 40 new medicines for the treatment of type 2 diabetes have been introduced on the market. These consist of 15 new active substances establishing three new classes of non-insulin products, and several new or modified insulin prod
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy. 3(3)
Autor:
Amy Egan, Kristina Dunder, Curtis Rosebraugh, B. Timothy Hummer, Pieter A. de Graeff, Todd Bourcier, Eberhard Blind
Publikováno v:
New England Journal of Medicine, 370(9), 794-797. MASSACHUSETTS MEDICAL SOC
After evaluating a safety signal regarding pancreatitis and pancreatic cancer in patients using incretin-based drugs, the Food and Drug Administration and the European Medicines Agency conclude that assertions of a causal association are inconsistent
Autor:
Jan Müller-Berghaus, Robert Hemmings, Dorota Distlerová, Anna M Stefanska, Richard Veselý, Tomas Salmonson, Dirk Mentzer, Thorsten M. Olski, Kristina Dunder, Joachim Musaus
Publikováno v:
Archives of disease in childhood. 102(10)
The European Union (EU) Paediatric Regulation requires that all new medicinal products applying for a marketing authorisation (MA) in the EU provide a paediatric investigation plan (PIP) covering a clinical and non-clinical trial programme relating t
Publikováno v:
Diabetologia, 54(2), 213-218. SPRINGER
Abbreviations CHF Congestive heart failure CHMP Committee for Medicinal Products for Human Use EMA European Medicines Agency FDA Food and Drug Administration MAH Marketing authorisation holder PROactive Prospective Pioglitazone Clinical Trial in Macr
Autor:
Staffan Welin, Britt Skogseid, Kristina Dunder, Kjell Öberg, Barbro Eriksson, Eva Tiensuu Janson, Henrik Kindmark, Dan Granberg, Anders Sundin
Publikováno v:
Medical Oncology. 24:330-337
Glucagon-secreting endocrine pancreatic tumor is a rare disease, hence controlled studies on clinical management are lacking. In an attempt to assess the efficacy of diagnostic and therapeutic measures in patients with glucagonoma, a retrospective st
Autor:
Britt Skogseid, Sara Ekeblad, Dan Granberg, Håkan Örlefors, Gordana Kozlovacki, Staffan Welin, Henrik Kindmark, Anders Sundin, Kjell Öberg, Barbro Eriksson, Eva Tiensuu Janson, Mattias Sigurd, Kristina Dunder
Publikováno v:
Clinical Cancer Research. 13:2986-2991
Purpose: A retrospective analysis of the toxicity and efficacy of temozolomide in advanced neuroendocrine tumors. Experimental Design: Thirty-six patients with advanced stages of neuroendocrine tumor (1 gastric, 7 thymic and 13 bronchial carcinoids,
Publikováno v:
American Heart Journal. 147:502-508
Ischemic heart disease can vary substantially in its clinical presentation. Some patients have acute myocardial infarction (MI) without any previous signs of myocardial ischemia, whereas other patients may have stable angina pectoris for years withou
Publikováno v:
Journal of Internal Medicine. 255:221-228
To evaluate risk factors and prognosis of subjects who had developed a new Q/QS pattern on the resting electrocardiogram (ECG) in relation to history of myocardial infarction (MI).Cross-sectional and prospective population-based cohort study.Uppsala,
Autor:
Christian Gisselbrecht, Tomas Salmonson, Francesco Pignatti, Edward Laane, Jan Sjöberg, Kristina Dunder, Elias Pean, Beatriz Flores, Ian Hudson
On May 10, 2012, the European Commission issued a conditional marketing authorization valid throughout the European Union for pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e37386a8f8f1031ded7ac884dfa5e6a
https://europepmc.org/articles/PMC3662855/
https://europepmc.org/articles/PMC3662855/